Acetyl-CoA carboxylase

亚型特异性产品

Acetyl-CoA carboxylase产品

  • 所有产品(9)
  • Acetyl-CoA carboxylase抑制剂 (7)
目录号 产品名 产品描述 文献引用 实验数据
S8893 Firsocostat (GS-0976, ND-630) Firsocostat (GS-0976, ND-630)是acetyl CoA carboxylase (ACC)的一种可逆抑制剂,对hACC1和hACC2的IC50分别为2.1 nM,6.1 nM。
Nat Commun, 2023, 14(1):1362
Genome Med, 2022, 14(1):67
Sci Adv, 2022, 8(47):eabq1984
S6753 CP 640186 CP 640186是ACC (Acetyl-CoA carboxylase)抑制剂,对大鼠肝脏ACC1和骨骼肌ACC2的IC50分别为53 nM和61 nM。
Exp Ther Med, 2020, 20(1):521-529
Molecules, 2015, 20(9):16221-34
Molecules, 2015, 20(9):16221-34
S8377 ND646 ND-646 是一种 ACC (Acetyl-coA carboxylase) enzymes 的变构抑制剂,可防止ACC亚基二聚化,从而抑制脂肪酸合成,对hACC1和hACC2的IC50值分别为3.5 nM和4.1 nM。
Cancer Discov, 2023, 13(2):496-515
Cancer Sci, 2023, 114(4):1651-1662
Cancer Sci, 2023, 114(4):1651-1662
S6690 TOFA TOFA 是acetyl-CoA carboxylase-α (ACCA)的变构抑制剂。在细胞内TOFA转化为TOFyl-CoA (5-tetradecyloxy-2-furoyl-CoA),对ACCA具有变构抑制作用。 TOFA阻止脂肪酸合成,并以剂量依赖性方式诱导细胞死亡。
bioRxiv, 2024, 2024.02.22.581432
Cancer Commun (Lond), 2022, 10.1002/cac2.12380
Sci Adv, 2021, 7(35)eabj0364
S6672 PF-05175157 PF-05175157是一种广谱有效的ACC抑制剂,对人ACC1,人ACC2,大鼠ACC1和大鼠ACC2的IC50分别为27.0 nM、33.0 nM、23.5 nM和50.4 nM。
Cancer Cell Int, 2023, 23(1):83
F0270New Acetyl-CoA Carboxylase Rabbit mAb Acetyl-CoA Carboxylase Rabbit mAb recognizes endogenous levels of total Acetyl-CoA Carboxylase protein.
S5519 4-Methylsalicylic acid 4-Methylsalicylic acid (m-Cresotic acid, 2-Hydroxy-4-methylbenzoic acid, m-Cresotinic acid, 2-Hydroxy-p-toluic acid) is used to inhibit the medium chain acyl-CoA synthetase.
S6145 PF-05221304 PF-05221304 是一种口服可生物利用的,肝靶向的 acetyl-CoA carboxylase (ACC) 的抑制剂,是一种催化脂肪从头生成(DNL)的第一步的酶。
S6112 Oxalacetic acid Oxalacetic acid (Oxaloacetic acid, 2-Oxosuccinic acid, Ketosuccinic acid)是三羧酸循环的中间物,它与乙酰辅酶A经柠檬酸合酶催化反应生成柠檬酸盐。它还参与糖原异生、尿素循环、乙醛酸循环、氨基酸合成和脂肪酸合成等过程。Oxaloacetate是Complex II的抑制剂。
S8893 Firsocostat (GS-0976, ND-630) Firsocostat (GS-0976, ND-630)是acetyl CoA carboxylase (ACC)的一种可逆抑制剂,对hACC1和hACC2的IC50分别为2.1 nM,6.1 nM。
Nat Commun, 2023, 14(1):1362
Genome Med, 2022, 14(1):67
Sci Adv, 2022, 8(47):eabq1984
S6753 CP 640186 CP 640186是ACC (Acetyl-CoA carboxylase)抑制剂,对大鼠肝脏ACC1和骨骼肌ACC2的IC50分别为53 nM和61 nM。
Exp Ther Med, 2020, 20(1):521-529
Molecules, 2015, 20(9):16221-34
Molecules, 2015, 20(9):16221-34
S8377 ND646 ND-646 是一种 ACC (Acetyl-coA carboxylase) enzymes 的变构抑制剂,可防止ACC亚基二聚化,从而抑制脂肪酸合成,对hACC1和hACC2的IC50值分别为3.5 nM和4.1 nM。
Cancer Discov, 2023, 13(2):496-515
Cancer Sci, 2023, 114(4):1651-1662
Cancer Sci, 2023, 114(4):1651-1662
S6690 TOFA TOFA 是acetyl-CoA carboxylase-α (ACCA)的变构抑制剂。在细胞内TOFA转化为TOFyl-CoA (5-tetradecyloxy-2-furoyl-CoA),对ACCA具有变构抑制作用。 TOFA阻止脂肪酸合成,并以剂量依赖性方式诱导细胞死亡。
bioRxiv, 2024, 2024.02.22.581432
Cancer Commun (Lond), 2022, 10.1002/cac2.12380
Sci Adv, 2021, 7(35)eabj0364
S6672 PF-05175157 PF-05175157是一种广谱有效的ACC抑制剂,对人ACC1,人ACC2,大鼠ACC1和大鼠ACC2的IC50分别为27.0 nM、33.0 nM、23.5 nM和50.4 nM。
Cancer Cell Int, 2023, 23(1):83
S5519 4-Methylsalicylic acid 4-Methylsalicylic acid (m-Cresotic acid, 2-Hydroxy-4-methylbenzoic acid, m-Cresotinic acid, 2-Hydroxy-p-toluic acid) is used to inhibit the medium chain acyl-CoA synthetase.
S6145 PF-05221304 PF-05221304 是一种口服可生物利用的,肝靶向的 acetyl-CoA carboxylase (ACC) 的抑制剂,是一种催化脂肪从头生成(DNL)的第一步的酶。
F0270New Acetyl-CoA Carboxylase Rabbit mAb Acetyl-CoA Carboxylase Rabbit mAb recognizes endogenous levels of total Acetyl-CoA Carboxylase protein.

Acetyl-CoA carboxylase抑制剂选择性比较

Tags: Acetyl-CoA carboxylase inhibitor|Acetyl-CoA carboxylase agonist|Acetyl-CoA carboxylase activator|Acetyl-CoA carboxylase inducer|Acetyl-CoA carboxylase antagonist|Acetyl-CoA carboxylase signaling pathway|Acetyl-CoA carboxylase assay kit
在线咨询
联系我们